QIAGEN N.V. (QGEN) Fundamental Analysis & Valuation

NYSE:QGEN • NL0015002SN0

Current stock price

34.58 USD
+0.97 (+2.89%)
At close:
34.58 USD
0 (0%)
After Hours:

This QGEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. QGEN Profitability Analysis

1.1 Basic Checks

  • In the past year QGEN was profitable.
  • QGEN had a positive operating cash flow in the past year.
  • Each year in the past 5 years QGEN has been profitable.
  • Each year in the past 5 years QGEN had a positive operating cash flow.
QGEN Yearly Net Income VS EBIT VS OCF VS FCFQGEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • The Return On Assets of QGEN (6.76%) is better than 84.21% of its industry peers.
  • With an excellent Return On Equity value of 11.25%, QGEN belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
  • The Return On Invested Capital of QGEN (7.25%) is better than 80.70% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for QGEN is below the industry average of 11.01%.
Industry RankSector Rank
ROA 6.76%
ROE 11.25%
ROIC 7.25%
ROA(3y)4.6%
ROA(5y)5.78%
ROE(3y)7.52%
ROE(5y)10.26%
ROIC(3y)7.27%
ROIC(5y)8.26%
QGEN Yearly ROA, ROE, ROICQGEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 20.33%, QGEN belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
  • In the last couple of years the Profit Margin of QGEN has remained more or less at the same level.
  • The Operating Margin of QGEN (25.71%) is better than 96.49% of its industry peers.
  • QGEN's Operating Margin has declined in the last couple of years.
  • QGEN has a better Gross Margin (62.99%) than 84.21% of its industry peers.
  • In the last couple of years the Gross Margin of QGEN has remained more or less at the same level.
Industry RankSector Rank
OM 25.71%
PM (TTM) 20.33%
GM 62.99%
OM growth 3Y-0.65%
OM growth 5Y-1.69%
PM growth 3Y0.95%
PM growth 5Y1.14%
GM growth 3Y-0.51%
GM growth 5Y-0.69%
QGEN Yearly Profit, Operating, Gross MarginsQGEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. QGEN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QGEN is destroying value.
  • QGEN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, QGEN has less shares outstanding
  • The debt/assets ratio for QGEN is higher compared to a year ago.
QGEN Yearly Shares OutstandingQGEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
QGEN Yearly Total Debt VS Total AssetsQGEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.22 indicates that QGEN is not in any danger for bankruptcy at the moment.
  • QGEN's Altman-Z score of 3.22 is fine compared to the rest of the industry. QGEN outperforms 71.93% of its industry peers.
  • The Debt to FCF ratio of QGEN is 3.70, which is a good value as it means it would take QGEN, 3.70 years of fcf income to pay off all of its debts.
  • QGEN has a Debt to FCF ratio of 3.70. This is in the better half of the industry: QGEN outperforms 75.44% of its industry peers.
  • QGEN has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • QGEN's Debt to Equity ratio of 0.44 is in line compared to the rest of the industry. QGEN outperforms 42.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.7
Altman-Z 3.22
ROIC/WACC0.87
WACC8.33%
QGEN Yearly LT Debt VS Equity VS FCFQGEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 3.90 indicates that QGEN has no problem at all paying its short term obligations.
  • QGEN has a Current ratio of 3.90. This is in the better half of the industry: QGEN outperforms 66.67% of its industry peers.
  • A Quick Ratio of 3.31 indicates that QGEN has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 3.31, QGEN is doing good in the industry, outperforming 64.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.9
Quick Ratio 3.31
QGEN Yearly Current Assets VS Current LiabilitesQGEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. QGEN Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 5.09% over the past year.
  • Measured over the past 5 years, QGEN shows a small growth in Earnings Per Share. The EPS has been growing by 0.60% on average per year.
  • QGEN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.65%.
  • QGEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.25% yearly.
EPS 1Y (TTM)5.09%
EPS 3Y-2.23%
EPS 5Y0.6%
EPS Q2Q%-3.44%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y-0.81%
Revenue growth 5Y2.25%
Sales Q2Q%3.69%

3.2 Future

  • QGEN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.75% yearly.
  • The Revenue is expected to grow by 7.04% on average over the next years.
EPS Next Y5.3%
EPS Next 2Y7.94%
EPS Next 3Y8.61%
EPS Next 5Y7.75%
Revenue Next Year6.7%
Revenue Next 2Y6.2%
Revenue Next 3Y6.16%
Revenue Next 5Y7.04%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QGEN Yearly Revenue VS EstimatesQGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
QGEN Yearly EPS VS EstimatesQGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. QGEN Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.00, QGEN is valued correctly.
  • Based on the Price/Earnings ratio, QGEN is valued cheaper than 92.98% of the companies in the same industry.
  • QGEN is valuated rather cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 13.28, which indicates a correct valuation of QGEN.
  • QGEN's Price/Forward Earnings ratio is rather cheap when compared to the industry. QGEN is cheaper than 94.74% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. QGEN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14
Fwd PE 13.28
QGEN Price Earnings VS Forward Price EarningsQGEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 94.74% of the companies in the same industry are more expensive than QGEN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, QGEN is valued cheaper than 85.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.93
EV/EBITDA 10.15
QGEN Per share dataQGEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • QGEN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.64
PEG (5Y)23.35
EPS Next 2Y7.94%
EPS Next 3Y8.61%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. QGEN Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.69%, QGEN is not a good candidate for dividend investing.
  • In the last 3 months the price of QGEN has falen by -35.57%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.11. QGEN pays more dividend than 96.49% of the companies in the same industry.
  • With a Dividend Yield of 0.69, QGEN pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.69%

5.2 History

  • QGEN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
QGEN Yearly Dividends per shareQGEN Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 12.77% of the earnings are spent on dividend by QGEN. This is a low number and sustainable payout ratio.
DP12.77%
EPS Next 2Y7.94%
EPS Next 3Y8.61%
QGEN Yearly Income VS Free CF VS DividendQGEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M
QGEN Dividend Payout.QGEN Dividend Payout, showing the Payout Ratio.QGEN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

QGEN Fundamentals: All Metrics, Ratios and Statistics

QIAGEN N.V.

NYSE:QGEN (4/30/2026, 8:13:12 PM)

After market: 34.58 0 (0%)

34.58

+0.97 (+2.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength10.81
Industry Growth92
Earnings (Last)02-05
Earnings (Next)05-04
Inst Owners75.98%
Inst Owner Change-0.97%
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap7.13B
Revenue(TTM)2.09B
Net Income(TTM)424.88M
Analysts72.5
Price Target55.29 (59.89%)
Short Float %2.83%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield 0.69%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP12.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.46%
Min EPS beat(2)-3.03%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)1.12%
Min EPS beat(4)-3.03%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.49%
EPS beat(12)7
Avg EPS beat(12)1.45%
EPS beat(16)11
Avg EPS beat(16)3.7%
Revenue beat(2)0
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.31%
Revenue beat(4)1
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.72%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)1
Avg Revenue beat(12)-0.7%
Revenue beat(16)5
Avg Revenue beat(16)-0.05%
PT rev (1m)-0.11%
PT rev (3m)2.06%
EPS NQ rev (1m)-0.7%
EPS NQ rev (3m)-6.38%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-3.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 14
Fwd PE 13.28
P/S 3.41
P/FCF 15.93
P/OCF 10.89
P/B 1.89
P/tB 10.31
EV/EBITDA 10.15
EPS(TTM)2.47
EY7.14%
EPS(NY)2.6
Fwd EY7.53%
FCF(TTM)2.17
FCFY6.28%
OCF(TTM)3.18
OCFY9.18%
SpS10.14
BVpS18.33
TBVpS3.35
PEG (NY)2.64
PEG (5Y)23.35
Graham Number31.9207 (-7.69%)
Profitability
Industry RankSector Rank
ROA 6.76%
ROE 11.25%
ROCE 9.31%
ROIC 7.25%
ROICexc 8.95%
ROICexgc 26.41%
OM 25.71%
PM (TTM) 20.33%
GM 62.99%
FCFM 21.4%
ROA(3y)4.6%
ROA(5y)5.78%
ROE(3y)7.52%
ROE(5y)10.26%
ROIC(3y)7.27%
ROIC(5y)8.26%
ROICexc(3y)9.11%
ROICexc(5y)10.64%
ROICexgc(3y)30.34%
ROICexgc(5y)44.67%
ROCE(3y)9.34%
ROCE(5y)10.61%
ROICexgc growth 3Y-15.51%
ROICexgc growth 5Y-0.67%
ROICexc growth 3Y-7.24%
ROICexc growth 5Y0.13%
OM growth 3Y-0.65%
OM growth 5Y-1.69%
PM growth 3Y0.95%
PM growth 5Y1.14%
GM growth 3Y-0.51%
GM growth 5Y-0.69%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 3.7
Debt/EBITDA 2.26
Cap/Depr 106.91%
Cap/Sales 9.91%
Interest Coverage 18.37
Cash Conversion 89.51%
Profit Quality 105.25%
Current Ratio 3.9
Quick Ratio 3.31
Altman-Z 3.22
F-Score6
WACC8.33%
ROIC/WACC0.87
Cap/Depr(3y)90.15%
Cap/Depr(5y)87.64%
Cap/Sales(3y)8.95%
Cap/Sales(5y)8.6%
Profit Quality(3y)264.36%
Profit Quality(5y)202.24%
High Growth Momentum
Growth
EPS 1Y (TTM)5.09%
EPS 3Y-2.23%
EPS 5Y0.6%
EPS Q2Q%-3.44%
EPS Next Y5.3%
EPS Next 2Y7.94%
EPS Next 3Y8.61%
EPS Next 5Y7.75%
Revenue 1Y (TTM)5.65%
Revenue growth 3Y-0.81%
Revenue growth 5Y2.25%
Sales Q2Q%3.69%
Revenue Next Year6.7%
Revenue Next 2Y6.2%
Revenue Next 3Y6.16%
Revenue Next 5Y7.04%
EBIT growth 1Y8.54%
EBIT growth 3Y-1.45%
EBIT growth 5Y0.51%
EBIT Next Year39.59%
EBIT Next 3Y17.75%
EBIT Next 5Y12.5%
FCF growth 1Y-10.97%
FCF growth 3Y-7.55%
FCF growth 5Y23.83%
OCF growth 1Y-2.85%
OCF growth 3Y-2.92%
OCF growth 5Y7.4%

QIAGEN N.V. / QGEN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for QIAGEN N.V.?

ChartMill assigns a fundamental rating of 6 / 10 to QGEN.


Can you provide the valuation status for QIAGEN N.V.?

ChartMill assigns a valuation rating of 6 / 10 to QIAGEN N.V. (QGEN). This can be considered as Fairly Valued.


How profitable is QIAGEN N.V. (QGEN) stock?

QIAGEN N.V. (QGEN) has a profitability rating of 7 / 10.


What are the PE and PB ratios of QIAGEN N.V. (QGEN) stock?

The Price/Earnings (PE) ratio for QIAGEN N.V. (QGEN) is 14 and the Price/Book (PB) ratio is 1.89.


What is the financial health of QIAGEN N.V. (QGEN) stock?

The financial health rating of QIAGEN N.V. (QGEN) is 7 / 10.